Accel Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
ATO
RG
ECSS
Accel Wealth Management's BSX Position: Q2 2026 in Review
Accel Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,841 shares — an estimated $241K sold.
Accel Wealth Management first reported a position in BSX in Q4 2020 and held it in 19 quarters. The position peaked at $478K in Q2 2025. 467 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Accel Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Accel Wealth Management sold 3,841 Boston Scientific shares in Q2 2026, an estimated $241K.
- Accel Wealth Management first reported a position in Boston Scientific in Q4 2020 and held it in 19 quarters.
- Accel Wealth Management's Boston Scientific position peaked at $478K in Q2 2025.
- 467 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.